CG Oncology CGON
NASDAQ CGON
$70.52 +0.91 (+1.31%)
At close: Sep 29, 2026 · 4:00 PM EDT

CG Oncology (CGON) Gross Margin (2024 - 2026)

Updated

CG Oncology's Gross Margin was -239.24% in Q2 2026, down 65.74 percentage points from the prior quarter.

Analysis

CG Oncology (CGON) Gross Margin (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, CG Oncology's Gross Margin was -85.20% through Jun 30, 2026, down 185.20 percentage points year-over-year; for FY2025, it came in at -15.02%, down 115.02 percentage points from FY2024.

  • In earlier years, Gross Margin was 100.00% in FY2024 (unchanged) and 100.00% in FY2023.
  • Per Business Quant data, CGON's Gross Margin in the three quarters before Q2 2026 was -173.50% (Q1 2026), -32.21% (Q4 2025) and 5.34% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 CG Oncology 6.15 Bn 6.15 Bn -2.77 Mn -239.24%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -239.24%
Mar 31, 2026 -173.50%
Dec 31, 2025 -32.21%
Sep 30, 2025 5.34%
Mar 31, 2025 100.00%
Dec 31, 2024 100.00%
Sep 30, 2024 100.00%
API Access

CG Oncology Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=CGON&period=max&api_key=YOUR_API_KEY